Comparison between SPL Industries IPO and Vivimed Labs IPO.
SPL Industries IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Vivimed Labs IPO is a Mainboard Fixed Price proposed to list at BSE, NSE.
The total issue size of SPL Industries IPO is up to ₹63.00 Cr whereas the issue size of the Vivimed Labs IPO is up to ₹17.51 Cr. The final issue price of SPL Industries IPO is ₹70.00 per share and of Vivimed Labs IPO is ₹70.00 per share.
| SPL Industries IPO | Vivimed Labs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹60.00 per share | |
| Issue Price (Upper) | ₹70.00 per share | |
| Issue Price (Final) | ₹70.00 per share | ₹70.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 90,00,000 shares | 25,01,429 shares |
| Fresh Issue Size (Amount) | up to ₹63.00 Cr | up to ₹17.51 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 90,00,000 shares | 25,01,429 shares |
| Issue Size Total (Amount) | up to ₹63.00 Cr | up to ₹17.51 Cr |
SPL Industries IPO opens on Jun 29, 2005, while Vivimed Labs IPO opens on Jul 09, 2005. The closing date of SPL Industries IPO and Vivimed Labs IPO is Jul 05, 2005, and Jul 13, 2005, respectively.
SPL Industries IPO P/E ratio is , as compared to Vivimed Labs IPO P/E ratio of .
| SPL Industries IPO | Vivimed Labs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 93.86 | 55.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.73 | 36.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.19 | 23.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the SPL Industries IPO Retail Individual Investors (RII) are offered 31,50,000 shares while in Vivimed Labs IPO retail investors are offered 31,50,000 shares. Qualified Institutional Buyers (QIB) are offered 45,00,000 shares in SPL Industries IPO and 0 shares in Vivimed Labs IPO.
| SPL Industries IPO | Vivimed Labs IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 45,00,000 shares | 0 shares |
| NII | 13,50,000 shares | 9,25,000 shares |
| RII | 31,50,000 shares | 9,25,000 shares |
| Employee | 0 shares | 50,000 shares |
| Others | ||
| Total | 90,00,000 shares | 25,00,000 shares |
SPL Industries IPO subscribed in total, whereas Vivimed Labs IPO subscribed .
